DOCS vs MRK
Doximity Inc (DOCS) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Doximity Inc (DOCS) is a health information services company listed on US.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
Latest reported MRK revenue for 2025-12-31 was $65.01B. Net income was $18.25B. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
DOCS currently screens at market cap $3.77B and trailing P/E 21.0. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the DOCS and MRK stock pages for the full models.
Not investment advice.